132 related articles for article (PubMed ID: 36087543)
21. [Ampullary Carcinoma-prognostic and Therapeutical Contrast to Pancreatic Ductal Adenocarcinoma].
Giehl-Brown E; Weitz J; Distler M
Zentralbl Chir; 2022 Apr; 147(2):160-167. PubMed ID: 35378556
[TBL] [Abstract][Full Text] [Related]
22. Oncologic outcomes in resected ampullary cancer: Relevance of histologic subtype and adjuvant chemotherapy.
Affi Koprowski M; Sutton TL; Brinkerhoff BT; Grossberg A; Sheppard BC; Mayo SC
Am J Surg; 2021 Jun; 221(6):1128-1134. PubMed ID: 33883071
[TBL] [Abstract][Full Text] [Related]
23. [Surgery for periampullary pancreatic cancer].
Hank T; Klaiber U; Sahora K; Schindl M; Strobel O
Chirurg; 2021 Sep; 92(9):776-787. PubMed ID: 34259884
[TBL] [Abstract][Full Text] [Related]
24. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
25. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
26. Very early recurrence following pancreaticoduodenectomy in patients with ampullary cancer.
Park HM; Park SJ; Han SS; Hong SK; Hong EK; Kim SW
Medicine (Baltimore); 2019 Nov; 98(44):e17711. PubMed ID: 31689805
[TBL] [Abstract][Full Text] [Related]
27. Transduodenal local resection for low-risk group ampulla of vater carcinoma.
Park JS; Yoon DS; Park YN; Lee WJ; Chi HS; Kim BR
J Laparoendosc Adv Surg Tech A; 2007 Dec; 17(6):737-42. PubMed ID: 18158802
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
29. Can endoscopic papillectomy be curative for early ampullary adenocarcinoma of the ampulla of Vater?
Alvarez-Sanchez MV; Oria I; Luna OB; Pialat J; Gincul R; Lefort C; Bourdariat R; Fumex F; Lepilliez V; Scoazec JY; Salgado-Barreira A; Lemaistre AI; Napoléon B
Surg Endosc; 2017 Apr; 31(4):1564-1572. PubMed ID: 27530895
[TBL] [Abstract][Full Text] [Related]
30. [Periampullary carcinoma or tumor of the ampulla of Vater?].
Vasilescu C; Herlea V; Stoicescu M
Chirurgia (Bucur); 2000; 95(5):401-6. PubMed ID: 14870549
[TBL] [Abstract][Full Text] [Related]
31. Ampullary cancer with pancreas divisum treated by endoscopic partial papillectomy: a case report.
Ito K; Noda Y; Fujita N; Horaguchi J; Kurose A; Sawai T
J Gastrointestin Liver Dis; 2011 Jun; 20(2):205-7. PubMed ID: 21725520
[TBL] [Abstract][Full Text] [Related]
32. Resection margin involvement and tumour origin in pancreatic head cancer.
Verbeke CS; Gladhaug IP
Br J Surg; 2012 Aug; 99(8):1036-49. PubMed ID: 22517199
[TBL] [Abstract][Full Text] [Related]
33. Pathologic Subtypes of Ampullary Adenocarcinoma: Value of Ampullary MDCT for Noninvasive Preoperative Differentiation.
Ivanovic AM; Alessandrino F; Maksimovic R; Micev M; Ostojic S; Gore RM; Mortele KJ
AJR Am J Roentgenol; 2017 Mar; 208(3):W71-W78. PubMed ID: 28095024
[TBL] [Abstract][Full Text] [Related]
34. First results from the Swedish National Pancreatic and Periampullary Cancer Registry.
Tingstedt B; Andersson B; Jönsson C; Formichov V; Bratlie SO; Öhman M; Karlsson BM; Ansorge C; Segersvärd R; Gasslander T
HPB (Oxford); 2019 Jan; 21(1):34-42. PubMed ID: 30097413
[TBL] [Abstract][Full Text] [Related]
35. Clinical outcomes of ampullary neoplasms in resected margin positive or uncertain cases after endoscopic papillectomy.
Sakai A; Tsujimae M; Masuda A; Iemoto T; Ashina S; Yamakawa K; Tanaka T; Tanaka S; Yamada Y; Nakano R; Sato Y; Kurosawa M; Ikegawa T; Fujigaki S; Kobayashi T; Shiomi H; Arisaka Y; Itoh T; Kodama Y
World J Gastroenterol; 2019 Mar; 25(11):1387-1397. PubMed ID: 30918431
[TBL] [Abstract][Full Text] [Related]
36. Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study.
Robert PE; Leux C; Ouaissi M; Miguet M; Paye F; Merdrignac A; Delpero JR; Schwarz L; Carrere N; Muscari F; Gayet B; Dussart D; Hamy A; Regenet N
Pancreas; 2014 Jul; 43(5):692-7. PubMed ID: 24713843
[TBL] [Abstract][Full Text] [Related]
37. The use of histopathological subtyping in patients with ampullary cancer: a nationwide analysis.
de Bakker J; Sommeijer D; Besselink M; Kazemier G; van Grieken N
World J Surg Oncol; 2022 Dec; 20(1):406. PubMed ID: 36566267
[TBL] [Abstract][Full Text] [Related]
38. The Diagnosis and Treatment of Ampullary Carcinoma.
Walter D; Schnitzbauer AA; Schulze F; Trojan J
Dtsch Arztebl Int; 2023 Oct; 120(43):729-735. PubMed ID: 37656482
[TBL] [Abstract][Full Text] [Related]
39. Ampullary cancer--a separate clinical entity?
Perysinakis I; Margaris I; Kouraklis G
Histopathology; 2014 May; 64(6):759-68. PubMed ID: 24456259
[TBL] [Abstract][Full Text] [Related]
40. Malignant tumours of the duodenum.
Ryska M; Hrabal P
Rozhl Chir; 2015 Dec; 94(12):497-503. PubMed ID: 26767899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
